Gujarat Kidney and Super Speciality Ltd has fixed the price band of Rs 108/- to Rs 114/- per Equity Share of face value Rs 2/- each for its maiden initial public offer. The Initial Public Issue (“IPO” or “Issue”) of the Company will open on Monday, December 22, 2025, for subscription and close on Wednesday, December 24, 2025. Investors can bid for a minimum of 128 Equity Shares and in multiples of 128 Equity Shares thereafter. Equity shares outstanding as on date 5,68,43,250 Equity Shares of Rs 2 each. The IPO is a fresh issue of up to 2,20,00,000 equity shares. The company is one of the regional healthcare companies located in the central region of Gujarat and operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care. We on a consolidated basis, operate seven (07) multispeciality hospitals and four (04) pharmacies operating within our Hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand), Ashwini Medical Store (Anand) and Apex Multispeciality & Trauma Center (Bharuch) with a total bed capacity of 490 beds, approved bed capacity of 445 beds and operational bed capacity of 340 beds.